STOCK TITAN

NewAmsterdam Pharma grants options, RSUs to VP

NAMS granted its Vice President, Controller a mix of stock options and RSUs with multi‑year service-based vesting schedules.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

NewAmsterdam Pharma Co N.V. (NAMS) reported that Vice President, Controller Robert William Gunning received equity compensation awards on September 1, 2026. He was granted options for 14,000 ordinary shares at an exercise price of $24.92 per share, expiring August 31, 2036, plus 3,200 restricted stock units, each representing one ordinary share. The RSUs vest in three equal annual installments beginning September 10, 2026, and 25% of the option shares vest on August 10, 2026, with the remainder vesting in equal monthly installments over the following three years, in each case subject to his continued service. No Rule 10b5-1 trading plan is reported.

Positive

  • None.

Negative

  • None.
Insider Gunning Robert William
Role Vice President, Controller
Type Security Shares Price Value
Grant/Award Option (right to buy) F2 14,000 $0.00 $0.00
Grant/Award Ordinary Shares F1 3,200 $0.00 $0.00
Holdings After Transaction: Option (right to buy) — 14,000 contracts (Direct); Ordinary Shares — 3,200 shares (Direct)
Footnotes (2)
  1. F1. Represents restricted stock units ("RSUs"), each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, September 10, 2026, subject to the Reporting Person's continued service through each such date.
  2. F2. 25% of the shares underlying the option will vest on August 10, 2026, the one-year anniversay of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.
Options granted 14,000 options Grant of stock options to Robert William Gunning on September 1, 2026
Option exercise price $24.92 per share Exercise price for 14,000 options expiring August 31, 2036
Options expiration date August 31, 2036 Expiry of options on 14,000 NAMS ordinary shares
RSUs granted 3,200 RSUs Restricted stock units granted September 1, 2026 to Robert William Gunning
RSU vesting start date September 10, 2026 Start date for 3-year, one-third-per-year RSU vesting schedule
Initial option vesting 25% on August 10, 2026 First vesting tranche of option award; remainder vests monthly over three years
Options held after grant 14,000 options Total option shares directly owned following the reported transaction
RSUs held after grant 3,200 RSUs Total RSUs directly owned following the reported transaction
restricted stock units ("RSUs") financial
"Represents restricted stock units ("RSUs"), each representing a contingent right"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
vesting start date financial
"on each of the first, second and third anniversaries of the vesting start date"
contingent right to receive one ordinary share financial
"each representing a contingent right to receive one ordinary share"
equal monthly installments financial
"with the remaining shares vesting in equal monthly installments thereafter"
continued service financial
"subject to the Reporting Person's continued service through each such date"

FAQ

What equity awards did NAMS grant to Vice President, Controller Robert William Gunning?

On September 1, 2026, he received options for 14,000 ordinary shares and 3,200 restricted stock units (RSUs). Each RSU represents a contingent right to receive one ordinary share, and the options carry an exercise price of $24.92 per share and expire August 31, 2036.

What is the vesting schedule for the 3,200 RSUs granted by NAMS (NAMS)?

The 3,200 RSUs vest in three equal installments: 1/3 on each of the first, second and third anniversaries of the vesting start date, September 10, 2026, subject to Robert William Gunning’s continued service through each vesting date.

How do the 14,000 NAMS stock options granted to Robert William Gunning vest?

For the 14,000 options, 25% of the underlying shares vest on August 10, 2026, the one-year anniversary of the vesting start date. The remaining shares vest in equal monthly installments over the following three years, subject to his continued service.

What is the exercise price and expiration date of the NAMS options granted?

The options granted to Robert William Gunning have an exercise price of $24.92 per share and an expiration date of August 31, 2036. After the grant, he held 14,000 option shares directly, according to the filing data.

Were the NAMS equity awards to Robert William Gunning made under a Rule 10b5-1 trading plan?

No. The filing indicates no Rule 10b5-1 trading plan is reported for these transactions. They are described as grants or awards rather than transactions executed under a pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gunning Robert William

(Last)(First)(Middle)
C/O NEWAMSTERDAM PHARMA COMPANY N.V.
GOOIMEER 2-35

(Street)
NAARDEN1411 DC

(City)(State)(Zip)

NETHERLANDS

(Country)
2. Issuer Name and Ticker or Trading Symbol
NewAmsterdam Pharma Co N.V. [ NAMS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Vice President, Controller
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares09/01/2026A3,200(1)A$03,200D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option (right to buy)$24.9209/01/2026A14,000 (2)08/31/2036Ordinary Shares14,000$0.0014,000D
Explanation of Responses:
1. Represents restricted stock units ("RSUs"), each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, September 10, 2026, subject to the Reporting Person's continued service through each such date.
2. 25% of the shares underlying the option will vest on August 10, 2026, the one-year anniversay of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.
/s/ Michael Marino, Attorney-in-Fact for Robert William Gunning09/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)